Yosuke Komata et al.
Nagoya journal of medical science, 83(3), 495-508 (2021-09-24)
Midkine (MK), a heparin-binding growth factor, is associated with the poor prognosis of the pediatric tumor, neuroblastoma. MK would be a druggable target as many studies showed inhibition of its function in various cancers suppressed tumor developments. To establish the